Information
-
Trademark
-
99302309
-
International Classifications
-
Filing Date
July 25, 2025
a year ago
-
Transaction Date
July 26, 2025
a year ago
-
Status Date
July 25, 2025
a year ago
-
Status Code
630
-
-
Attorney Docket Number
CEL-T0002
Attorney Name
Cy Bates
-
Owners
- Cellcura Sciences, Inc. (Lehi, UT, US)
Case File Statements
- DM0000: The mark consists of mirror‑image curves resembling capital letters “C” positioned back‑to‑back, opening toward the outer edges of the design. The facing inner tips of the two curves define an elongated horizontal space. Centered within that space is a horizontal row of ten vertically oriented ovals that alternate in size.
- GS0051: Medical cleansers for skin and wounds; Liquid bandages for skin wounds; Pharmaceutical preparations for skin wounds; Bandages for skin wounds; Pharmaceutical preparations for wounds; Biological preparations for the treatment of musculoskeletal and orthopedic conditions including osteoarthritis, tendon and ligament injuries, fractures and non-unions, bulging or herniated discs, degenerative disc disease, carpal tunnel syndrome, cartilage injuries, muscle injuries, temporomandibular joint (TMJ) disorder, piriformis syndrome, sciatica, sacroiliac (SI) joint dysfunction, and osteonecrosis; Biological preparations for the treatment of autoimmune and inflammatory conditions including multiple sclerosis (MS), Crohn’s disease, and rheumatoid arthritis; Biological preparations for the treatment of neurological conditions including stroke, dementia, Parkinson’s disease, Huntington’s disease, spinal cord injury, post-concussion syndrome, and autism spectrum disorder; Biological preparations for the treatment of cardiovascular diseases including heart failure, peripheral artery disease, ischemic heart disease, and general cardiovascular disease; Biological preparations for the treatment of metabolic diseases including Type 1 and Type 2 diabetes, and obesity; Biological preparations for the treatment of hematological and immune diseases including, leukemia, lymphoma, myeloma, myelodysplastic syndrome, and myeloproliferative disorders; Biological preparations for the treatment of ophthalmologic conditions including macular degeneration, retinal detachment, and macular hole; Biological preparations for the treatment of liver and gastrointestinal diseases including chronic liver diseases, cirrhosis, liver failure, and Inflammatory bowel disease; Biological preparations for the treatment of chronic pain and degenerative conditions including fibromyalgia, chronic joint pain, and chronic wounds or non-healing ulcers
- GS0031: Beauty serums; Cosmetic preparations for eyelashes; Eyebrow cosmetics; Non-medicated hair serums; Non-medicated serums for use on eyelashes and eyebrows; Serums for cosmetic purposes; Skin care products, namely, non-medicated skin serum; Facial cream
Case File Event Statements
-
7/25/2025 - a year ago
1 - NEW APPLICATION ENTERED
Type: NWAP
-
7/25/2025 - a year ago
2 - APPLICATION FILING RECEIPT MAILED
Type: MAFR